Discussion on CBER's Plans for 2023 and Dr. Peter Marks' Hobbies

We love to hear from our listeners. Send us a message.

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER) within the Food and Drug Administration (FDA) sits down with Cell & Gene: The Podcast host Erin Harris to discuss the most anticipated areas of innovation in clinical development, and he offers recommendations to companies in their engagement with the FDA in order to make manufacturing more streamlined and cost effective. Dr. Marks also provides advice to listeners about how and when to engage with CBER, and much more.

Subscribe to the podcast!
Apple | Spotify | YouTube